Leanne is Professor of Psychiatry and Behavioral Sciences at Stanford University. At Stanford Dr. Williams is developing new precision medicine models for mental health. She founded the Williams’ Panlab for Precision Mental Health and Translational Neuroscience. She also leads department-wide initiatives in precision mental health as Associate Chair of Research Strategy and as the Chair of a research incubator that harnesses the activities of major labs focused on clinical translational neuroscience. She has a joint position at the Palo Alto VA Mental Illness Research, Education and Clinical Center where she is Director of education and dissemination, focused on post-traumatic stress and associated health issues. Dr. Williams first came to Stanford as a visiting Professor in 2011. At that time she was leading a multi-site international study to identify brain biomarkers for depression and antidepressant response. She was thrilled to join the Stanford faculty in 2013. Prior to this time she was foundation Professor of Cognitive Neuropsychiatry at the Sydney Medical School and Director of the interdisciplinary Sydney Brain Dynamics Center for 12 years. Her research programs center around three primary themes: 1. Defining and understanding the organization of large-scale human brain circuits and how these circuits generate complex human behaviors such as emotional response and regulation, cognitive control and self-reflective thought. Under this theme she integrates data across neuroimaging, behavioral, self-report and genetic modalities, and pursues new computational approaches to understand the linkages between these modalities; 2. Identifying naturally occurring types of mental disorder characterized by disruptions to large-scale brain circuits and the associated impact on behavior and subjective experience. Under this approach she goes beyond traditional psychiatric diagnostic boundaries and also encompasses comborbid mental and general health issues and 3. Harnessing new insights from human neuroscience and related psychosocial factors in order to guide the choice among current treatment options and to help develop novel therapeutics, to improve outcomes for each person. Dr. Williams’ research has contributed over 250 publications to the field and attracted awards that include the $1M Pfizer Foundation Research award and the American Psychosomatic Society Presidential award.